• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

终末期肝病模型(MELD)评分及器官共享联合网络(UNOS)成人肝脏分配系统概述。

Overview of the MELD score and the UNOS adult liver allocation system.

作者信息

Martin A P, Bartels M, Hauss J, Fangmann J

机构信息

Department of Visceral and Transplant Surgery, Universitetsklinik Leipzig, Leipzig, Sachsen, Germany.

出版信息

Transplant Proc. 2007 Dec;39(10):3169-74. doi: 10.1016/j.transproceed.2007.04.025.

DOI:10.1016/j.transproceed.2007.04.025
PMID:18089345
Abstract

On February 27, 2002, the United Network for Organ Sharing (UNOS) introduced a new allocation policy for cadaveric liver transplants, based on the Model for End-Stage Liver Disease (MELD) score. This new policy stratifies the patients based on their risk of death while on the waiting list. We analyzed the background and main features of this new allocation policy to evaluate the effects on waiting list dynamics as well as the accuracy of MELD as a predictor of pretransplantation mortality and posttransplantation outcome. MELD has proved to be accurate as a predictor of waiting list mortality, but seems to be less accurate to predict posttransplantation outcome. Immediate effects of the new policy were a reduction in the waiting list, while organs were primarily directed to sicker patients with reduced waiting times. There was a statistically but not significantly reduced number of patients removed from the list due to death or severity of sickness. The balance between medical urgency and transplant benefit is still to be defined as is the relationship between pretransplantation criteria and posttransplantation outcomes, and the way this relationship should be included in the allocation policy.

摘要

2002年2月27日,器官共享联合网络(UNOS)推出了一项基于终末期肝病模型(MELD)评分的尸体肝脏移植新分配政策。这项新政策根据患者在等待名单上的死亡风险对其进行分层。我们分析了这项新分配政策的背景和主要特征,以评估其对等待名单动态的影响,以及MELD作为移植前死亡率和移植后结果预测指标的准确性。事实证明,MELD作为等待名单死亡率的预测指标是准确的,但在预测移植后结果方面似乎不太准确。新政策的直接影响是等待名单人数减少,同时器官主要分配给病情更严重、等待时间更短的患者。因死亡或病情严重程度而从名单上移除的患者数量在统计学上有所减少,但并不显著。医疗紧迫性和移植益处之间的平衡仍有待确定,移植前标准与移植后结果之间的关系以及这种关系应如何纳入分配政策也有待确定。

相似文献

1
Overview of the MELD score and the UNOS adult liver allocation system.终末期肝病模型(MELD)评分及器官共享联合网络(UNOS)成人肝脏分配系统概述。
Transplant Proc. 2007 Dec;39(10):3169-74. doi: 10.1016/j.transproceed.2007.04.025.
2
Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.在一个单一中心进行的198例肝移植手术中,终末期肝病模型(MELD)评分与尸体供体的器官分配情况。
Transplant Proc. 2008 Jul-Aug;40(6):1903-5. doi: 10.1016/j.transproceed.2008.05.016.
3
Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality?终末期肝病模型:新的肝脏分配政策是否影响等待名单上的死亡率?
Arch Surg. 2007 Nov;142(11):1079-85. doi: 10.1001/archsurg.142.11.1079.
4
Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.终末期肝病模型评分引入前后肝移植等待名单上的生存率
Transplant Proc. 2010 Mar;42(2):407-11. doi: 10.1016/j.transproceed.2010.01.005.
5
Model for end-stage liver disease (MELD) and allocation of donor livers.终末期肝病模型(MELD)与供肝分配
Gastroenterology. 2003 Jan;124(1):91-6. doi: 10.1053/gast.2003.50016.
6
Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?用于评估等待肝移植患者的终末期肝病模型(MELD)评分系统:比Child-Turcotte-Pugh(CTP)系统更好吗?
Transplant Proc. 2008 Jul-Aug;40(6):1906-9. doi: 10.1016/j.transproceed.2008.05.072.
7
Risk factors for liver transplantation waiting list mortality.肝移植等待名单死亡率的风险因素。
J Gastroenterol Hepatol. 2007 Jan;22(1):119-24. doi: 10.1111/j.1440-1746.2006.04422.x.
8
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system.在终末期肝病模型系统内针对等待肝移植的肝细胞癌患者的一项新的优先政策。
Liver Transpl. 2007 Jun;13(6):857-66. doi: 10.1002/lt.21155.
9
Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival?终末期肝病模型(MELD)评分是否不仅足以预测等待名单上的死亡,还能预测移植后的生存率?
Transpl Int. 2006 Apr;19(4):275-81. doi: 10.1111/j.1432-2277.2006.00250.x.
10
Model for End-Stage Liver Disease (MELD) system to allocate and to share livers: experience of two Italian centers.终末期肝病模型(MELD)系统用于肝脏分配与共享:两个意大利中心的经验
Transplant Proc. 2008 Jul-Aug;40(6):1814-5. doi: 10.1016/j.transproceed.2008.05.053.

引用本文的文献

1
Comparison of Mortality Prediction Between the Model for End-Stage Liver Disease-3.0 (MELD-3.0) and the Model for End-Stage Liver Disease-Lactate (MELD-La) in Korean Patients with Liver Cirrhosis.韩国肝硬化患者中终末期肝病模型3.0(MELD-3.0)与终末期肝病-乳酸模型(MELD-La)死亡率预测的比较
Medicina (Kaunas). 2025 Mar 13;61(3):494. doi: 10.3390/medicina61030494.
2
The Association Between Cytomegalovirus Infection and Kidney Damage in the Liver Transplant Setting.肝移植环境中巨细胞病毒感染与肾损伤之间的关联。
Viruses. 2024 Nov 26;16(12):1830. doi: 10.3390/v16121830.
3
The Predictive Value of the MELD Scores for In-Hospital Adverse Events in Normotensive Patients with Acute Pulmonary Embolism.
MELD 评分对血压正常的急性肺栓塞患者住院不良事件的预测价值。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241266607. doi: 10.1177/10760296241266607.
4
Liver Severity Score-Based Modeling to Predict Six-Week Mortality Risk Among Hospitalized Cirrhosis Patients With Upper Gastrointestinal Bleeding.基于肝脏严重程度评分的模型预测上消化道出血的肝硬化住院患者六周死亡风险
J Clin Exp Hepatol. 2024 Jan-Feb;14(1):101255. doi: 10.1016/j.jceh.2023.07.402. Epub 2023 Jul 17.
5
Development and Validation of a Novel Tool to Predict Model for End-Stage Liver Disease (MELD) Scores in Cirrhosis, Using Administrative Datasets.利用管理数据集开发并验证一种预测肝硬化终末期肝病模型(MELD)评分的新型工具。
Clin Epidemiol. 2023 Mar 14;15:349-362. doi: 10.2147/CLEP.S387253. eCollection 2023.
6
Expert Insights on Current Treatments for Hepatocellular Carcinoma: Clinical and Molecular Approaches and Bottlenecks to Progress.肝细胞癌当前治疗方法的专家见解:临床与分子方法及进展瓶颈
J Hepatocell Carcinoma. 2022 Dec 7;9:1247-1261. doi: 10.2147/JHC.S383922. eCollection 2022.
7
TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery.TRI-SCORE:一种用于预测孤立性三尖瓣手术后院内死亡率的新风险评分。
Eur Heart J. 2022 Feb 12;43(7):654-662. doi: 10.1093/eurheartj/ehab679.
8
Validation of a new prognostic model to predict short and medium-term survival in patients with liver cirrhosis.验证一种新的预后模型,以预测肝硬化患者的短期和中期生存率。
BMC Gastroenterol. 2020 Aug 12;20(1):265. doi: 10.1186/s12876-020-01407-8.
9
Risk factors of acute kidney injury after orthotopic liver transplantation in China.中国原位肝移植术后急性肾损伤的危险因素。
Sci Rep. 2017 Jan 30;7:41555. doi: 10.1038/srep41555.
10
Living donor liver transplantation for high model for end-stage liver disease score: What have we learned?活体肝移植用于终末期肝病模型评分较高者:我们学到了什么?
World J Hepatol. 2016 Aug 8;8(22):942-8. doi: 10.4254/wjh.v8.i22.942.